hypothesis™ Provides New Guidance for Childhood Eczema and the Microbiome

New Guidance Helps Parents Understand Infant Skin Vulnerability and Bacterial Imbalance A child's eczema severity often ...
Rheumatology Advisor

Assisted Reproductive Technology Linked to Atopic Disease Risk in Offspring

Children conceived via assisted reproductive technology (ART) have a higher risk for developing atopic disease.

New Spherix Patient Research Shows Nearly Half of Atopic Dermatitis Patients Report Major Quality-of-Life Impact Despite Expanding Treatment Options

More than 31 million Americans are living with eczema/ atopic dermatitis (AD), a chronic inflammatory skin condition that extends far beyond visible symptoms to disrupt sleep, mental health, and daily ...
Welltica+ on MSN

Can dietary supplements affect the skin? Research provides answers

Here, a large proportion of studies show that probiotics in particular may have a positive effect, either by reducing ...
Rheumatology Advisor

Iron Deficiency Without Anemia Common With Moderate-to-Severe Atopic Dermatitis

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published online Nov. 27 in Nutrients.
BioSpace

J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark

J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...
Medscape

More Systemic Therapies Coming for Pediatric Skin Diseases

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.
The Malaysian Reserve

Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries

Cerapro® is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE ...

Hyphens Pharma International Limited: Hyphens Pharma out-licences Cerapro MED Skin Barrier Cream for six European countries

Cerapro is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE Mark)Product launch targeted for 2026 in six European ...